Lanean...
Positron Emission Tomography Molecular Imaging Biomarkers for Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder with limited treatment options. Despite decades of therapeutic development, only two modestly efficacious disease-modifying drugs—riluzole and edaravone—are available to ALS patients. Biomarkers that can facilitate ALS diagnos...
Gorde:
Egile Nagusiak: | , |
---|---|
Formatua: | Artigo |
Hizkuntza: | Inglês |
Argitaratua: |
Frontiers Media S.A.
2019-03-01
|
Saila: | Frontiers in Neurology |
Gaiak: | |
Sarrera elektronikoa: | https://www.frontiersin.org/article/10.3389/fneur.2019.00135/full |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|